Mutant EGFR inhibitor |
| Catalog No.GC11126 |
돌연변이 EGFR 억제제는 특허 WO 2013014448 A1에서 추출한 강력하고 선택적인 돌연변이 EGFR 억제제입니다. EGFRL858R, EGFRExon 19 결실 및 EGFRT790M을 억제합니다.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1421373-62-7
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Mutant EGFR inhibitor is a selective and potent Mutated EGFR inhibitor(L858R activating mutant, the Exonl9 deletion activating mutant and the T790M resistance mutant).
Review for Mutant EGFR inhibitor
Average Rating: 5 (Based on Reviews and 24 reference(s) in Google Scholar.)
Review for Mutant EGFR inhibitor
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *